News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017
News Daily News Amount of Calcium, Not Calcium Progression, May Be Best for Gauging CV Risk Michael H. Wilson July 07, 2016
News Daily News Does the Atherosclerotic Cardiovascular Disease Calculator Overestimate Patient Risk? The Debate Continues Yael L. Maxwell May 04, 2016